Shukra Pharmaceuticals Limited Profit Margin

Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) currently reports a profit margin of 45.4% as of June 2026. That compares with 29.08% in the prior-year period — up 56.1% year over year. That is above the sector sector average of 13.2%. Use the charts on this page to explore Shukra Pharmaceuticals Limited's profit margin history and peer comparisons.

Shukra Pharmaceuticals Limited's profit margin increased from 29.08% to 45.4% — a 56.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Shukra Pharmaceuticals Limited's profit margin of 45.4% is higher than the its sector sector average of 13.2%. That is roughly 244.0% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Shukra Pharmaceuticals Limited's current 45.4% should be judged against industry norms (sector average: 13.2%) and against SHUKRAPHAR.BO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 45.4%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.2%. From there, open related valuation or income-statement pages for Shukra Pharmaceuticals Limited, and consider following SHUKRAPHAR.BO for alerts when major investors trade the stock.